ArticleHeliyon2024
Epidemiological modeling of COVID-19 data with Advanced statistical inference based on Type-II progressive censoring.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research proposes the Kavya-Manoharan Unit Exponentiated Half Logistic (KM-UEHL) distribution as a novel tool for epidemiological modeling of COVID-19 data. Specifically designed to analyze data constrained to the unit interval, the KM-UEHL distribution builds upon the unit exponentiated half logistic model, making it suitable for various data from COVID-19. The paper emphasizes the KM-UEHL distribution's adaptability by examining its density and hazard rate functions. Its effectiveness is demonstrated in handling the diverse nature of COVID-19 data through these functions. Key characteristics like moments, quantile functions, stress-strength reliability, and entropy measures are also comprehensively investigated. Furthermore, the KM-UEHL distribution is employed for forecasting future COVID-19 data under a progressive Type-II censoring scheme, which acknowledges the time-dependent nature of data collection during outbreaks. The paper presents various methods for constructing prediction intervals for future-order statistics, including maximum likelihood estimation, Bayesian inference (both point and interval estimates), and upper-order statistics approaches. The Metropolis-Hastings and Gibbs sampling procedures are combined to create the Markov chain Monte Carlo simulations because it is mathematically difficult to acquire closed-form solutions for the posterior density function in the Bayesian framework. The theoretical developments are validated with numerical simulations, and the practical applicability of the KM-UEHL distribution is showcased using real-world COVID-19 datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.